Literature DB >> 32353352

Impact of Telephone Communication on Patient Adherence With Follow-Up Recommendations After an Abnormal Screening Mammogram.

Derek L Nguyen1, Eniola Oluyemi1, Kelly S Myers1, Susan C Harvey2, Lisa A Mullen1, Emily B Ambinder3.   

Abstract

OBJECTIVE: The Mammography Quality Standards Act requires written communication to every patient after an abnormal screening mammogram. Starting in 2013, our institution began telephoning all patients with a Breast Imaging Reporting and Data System (BI-RADS) assessment 0 on the next business day to schedule their diagnostic follow-up. Our aim is to analyze the changes in adherence and time to follow-up of patients recalled from screening mammography after the implementation of telephone communication.
METHODS: This retrospective study reviewed data from screening mammograms at our institution with a BI-RADS 0 assessment excluding technical recalls between January 1, and December 31, 2011 (pre-intervention group), 2014 (early post-intervention group), and 2018 (later post-intervention group). We compared patient adherence with timely follow-up diagnostic mammography (within 60 days) in these three groups using univariate and multivariate logistic regression. Cox proportional hazards regression analysis was done to evaluate the impact of telephone communication on time to follow-up.
RESULTS: This study included 1899 women in 2011, 2829 women in 2014, and 1999 women in 2018. We found that 73.1% patients in 2011 returned for their diagnostic follow-up within 60 days compared to 87.6% in 2014 and 90.0% in 2018, P < 0.001. Median time to follow-up in 2011 was 28 days (IQR 17-76 days) compared to 15 days (IQR 9-28 days) in 2014 and 9 days (IQR 5-18) in 2018, P < 0.001.
CONCLUSION: A higher percentage of women were adherent with a timely diagnostic follow-up examination after an abnormal screening mammogram with the addition of telephone communication.
Copyright © 2020 American College of Radiology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32353352     DOI: 10.1016/j.jacr.2020.03.030

Source DB:  PubMed          Journal:  J Am Coll Radiol        ISSN: 1546-1440            Impact factor:   5.532


  7 in total

Review 1.  BI-RADS 3 Assessment on MRI: A Lesion-Based Review for Breast Radiologists.

Authors:  Derek L Nguyen; Kelly S Myers; Eniola Oluyemi; Lisa A Mullen; Babita Panigrahi; Joanna Rossi; Emily B Ambinder
Journal:  J Breast Imaging       Date:  2022-06-28

2.  Delays in Follow-up Care for Abnormal Mammograms in Mobile Mammography Versus Fixed-Clinic Patients.

Authors:  Suzanne S Vang; Alexandra Dunn; Laurie R Margolies; Lina Jandorf
Journal:  J Gen Intern Med       Date:  2022-02-25       Impact factor: 6.473

3.  Serum semaphorin4C as an auxiliary diagnostic biomarker for breast cancer.

Authors:  Ya Wang; Jiahao Liu; Jiali Li; Huayi Li; Xiong Li; Long Qiao; Jie Yang; Tian Fang; Shaoqi Chen; Jingjing Ma; Junxiang Wan; Xingrui Li; Lin Zhang; Yun Xia; Yaqun Wu; Tao Xu; Jun Shao; Yaojun Feng; Ihab R Kamel; Qifeng Yang; Zhen Li; Qinglei Gao
Journal:  Clin Transl Med       Date:  2021-08

Review 4.  Addressing Disparities Related to Access of Multimodality Breast Imaging Services Before and During the COVID-19 Pandemic.

Authors:  Derek L Nguyen; Emily B Ambinder; Kelly S Myers; Eniola Oluyemi
Journal:  Acad Radiol       Date:  2022-03-25       Impact factor: 5.482

5.  The added value of an artificial intelligence system in assisting radiologists on indeterminate BI-RADS 0 mammograms.

Authors:  Chunyan Yi; Yuxing Tang; Rushan Ouyang; Yanbo Zhang; Zhenjie Cao; Zhicheng Yang; Shibin Wu; Mei Han; Jing Xiao; Peng Chang; Jie Ma
Journal:  Eur Radiol       Date:  2021-09-15       Impact factor: 7.034

6.  Guest Editorial for: "Addressing Disparities Related to Access of Multimodality Breast Imaging Services Before and During the COVID-19 Pandemic".

Authors:  Carolynn M DeBenedectis
Journal:  Acad Radiol       Date:  2022-09-06       Impact factor: 5.482

7.  Impact of Improved Screening Mammography Recall Lay Letter Readability on Patient Follow-Up.

Authors:  Derek L Nguyen; Susan C Harvey; Eniola T Oluyemi; Kelly S Myers; Lisa A Mullen; Emily B Ambinder
Journal:  J Am Coll Radiol       Date:  2020-07-30       Impact factor: 5.532

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.